本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Artelo Biosciences, Inc.

11.03
+1.5316.11%
盘后11.940.9074+8.23%19:59 EDT
成交量:50.09万
成交额:571.97万
市值:602.97万
市盈率:-0.61
高:13.22
开:9.81
低:9.81
收:9.50
数据加载中...
2021/01/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/01/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/16

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/04

重要事件披露

8-K - Current report
2020/12/02

重要事件披露

8-K - Current report
2020/11/20

重要事件披露

8-K - Current report
2020/11/04

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/10/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/14

重要事件披露

8-K - Current report
2020/10/08

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/07

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/07

SEC问询函

CORRESP [Cover] - Correspondence